Clinical Trial Update: Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating Fludeoxyglucose F-18 PET/CT imaging to assess chemotherapy response in newly diagnosed Hodgkin lymphoma across stages…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Fludeoxyglucose F-18 (Fludeoxyglucose F-18)

Snippet

Sponsor: University College, London | Conditions: Lymphoma | Phase 3 | Status: COMPLETED